Figure 2:
Kaplan Meier survival analysis of time to start anticoagulation categories versus recurrent ischemic event (A), symptomatic intracranial hemorrhagic (B), and combined events (C).
Kaplan Meier survival analysis of time to start anticoagulation categories versus recurrent ischemic event (A), symptomatic intracranial hemorrhagic (B), and combined events (C).